Key Highlights

On September 3, 2025, the U.S. Court of Appeals for the Eighth Circuit set aside the Tax Court’s ruling in Medtronic, Inc. v. Commissioner (Nos. 23-3063 & 23-3281). The appellate court held that the Tax Court erred in applying an unspecified hybrid method to determine the intercompany royalty rates for intangible property used in the manufacture of certain medical devices and leads.

In a significant development for transfer pricing jurisprudence, the Eighth Circuit concluded that the Tax Court both departed from the regulatory framework and applied an incorrect standard in rejecting the Comparable Profits Method (CPM). The case has been remanded for reconsideration under the proper analytical lens prescribed by Treas. Reg. §1.482-1(c).

Background and the Tax Court’s Approach

The Medtronic case has long been one of the most closely watched U.S. transfer pricing disputes. It concerns the allocation of income between Medtronic U.S., which owns valuable intellectual property related to pacemakers and other medical devices, and its Puerto Rico manufacturing affiliate, which uses that IP under a license arrangement.

In earlier proceedings, the Tax Court crafted an unspecified hybrid method that blended elements of a modified Comparable Uncontrolled Transaction (CUT) analysis with a variant of CPM and a residual profit split. This composite approach resulted in a royalty rate of 48.8%, allocating approximately 69% of system profits to the U.S. parent and 31% to the Puerto Rican affiliate.

The Eighth Circuit found this construction unsupported by the regulations, emphasizing that unspecified or hybrid methods must still satisfy the “best method” standard and demonstrate comparability on a principled basis. The court faulted the Tax Court for mixing methodologies without clear justification, thereby creating a result that lacked transparency and consistency with §1.482-1 principles.

Eighth Circuit’s Reasoning

The appellate court’s opinion provides a pointed critique of the Tax Court’s reasoning on three fronts:

1. Improper Rejection of CPM:

The Tax Court had dismissed CPM on the grounds that it did not adequately capture the value of Medtronic’s intangibles. The Eighth Circuit, however, observed that CPM is not inherently unreliable for IP-driven cases and that its rejection must be factually substantiated, not theoretically presumed.

2. Failure to Address Comparability Factors:

The Eighth Circuit directed the Tax Court to make specific factual findings regarding comparability adjustments, particularly those relating to assets employed, functions performed, and risks assumed by each entity.

3. Insufficient Consideration of Risk and Alternatives:

The appellate panel also instructed the Tax Court to examine product liability risk, commercial alternatives, and economic substance, key determinants of arm’s length behavior that were glossed over in the prior ruling.

Analytical Perspective

The decision is a clear rebuke of ad hoc transfer pricing constructions that fall outside the prescribed methods without strong empirical justification. While the Tax Court sought to craft an equitable middle ground, the Eighth Circuit’s insistence on methodological discipline underscores that judicial discretion cannot substitute for regulatory compliance.

From a policy standpoint, the decision may revitalize CPM’s role in complex cases involving intangibles, contrary to the perception that CPM is too simplistic for high-value IP scenarios. The appellate court’s focus on comparability adjustments also signals that CPM can be viable if economic differences are adequately quantified, rather than dismissed outright.

Practitioners note that this ruling aligns with the IRS’s long-standing preference for CPM, particularly where reliable CUTs are unavailable or intangible contributions are difficult to isolate. In effect, the Eighth Circuit has reaffirmed that simplicity of structure is not a flaw if the result is grounded in data and consistent application.

Why This Matters

The Medtronic decision signals a broader judicial tightening around the use of unspecified or blended methods in transfer pricing. Key takeaways include:

• Courts will expect strict adherence to the “best method” rule, with any departure from specified methods requiring rigorous evidentiary support.
• Hybrid or improvised approaches, though appealing for their flexibility, are now likely to face greater scepticism unless clearly justified by data.
• The decision reinforces that methodological transparency and economic realism must guide all intercompany pricing decisions, particularly in IP-heavy sectors.

For multinational groups with intangible-driven profit centers, especially those in low-tax or incentive jurisdictions, the ruling serves as a reminder that robust factual grounding and methodological consistency remain critical in sustaining their transfer pricing positions.

Next Steps

In light of the Eighth Circuit’s guidance, taxpayers should consider the following actions:

• Revisit Method Selection: Evaluate whether the chosen method truly satisfies the “best method” test under §1.482-1(c), and document why alternatives (including CPM) are less reliable.
• Reassess CPM Application: Test CPM defensibility through careful selection of the tested party, profit level indicators, and comparability adjustments.
• Strengthen Risk Documentation: Provide quantitative analysis of risk allocation, including exposure to product liability or market volatility.
• Analyze Realistic Alternatives: Clearly document whether manufacturing relocation, outsourcing, or alternative licensing models were viable.
• Avoid Over-Customized Blends: Any deviation from standard methods should be justified with robust data and explicit reasoning.

Lessons for Practitioners

1. Stay Within Recognized Methods: Courts are skeptical of hybrid approaches unless clearly justified.
2. CPM Is Valid for IP-Rich Structures: Properly adjusted CPM remains defensible, even with valuable intangibles.
3. Document Economic Substance: Show who performs and controls key functions, and who bears risks.
4. Substance Over Engineering: Hybrid models fail if not grounded in reproducible, evidence-backed economics.
5. Expect IRS Scrutiny: Post-Medtronic, CPM audits may intensify for royalty arrangements involving low-tax affiliates.

Outlook

As the case returns to the Tax Court, the next phase of Medtronic promises to be a landmark moment for defining the contours of method selection in U.S. transfer pricing. The forthcoming decision will likely serve as a reference point for future disputes involving royalty arrangements and intangibles, not only in the U.S. but also in OECD-aligned jurisdictions that mirror the U.S. “best method” philosophy.

The Eighth Circuit’s message is unmistakable: transfer pricing is not an art of compromise; it is a discipline grounded in comparability, method, and evidence.

Share via